Gut microbial metabolite short-chain fatty acids and obesity

Over the past decade, the gut microbiota has emerged as an essential mediator in the pathophysiology of obesity and related metabolic disorders. In this context, the reciprocal interactions of the gut microbiota structure and their metabolite profiles with host metabolism predisposing to a range of pathological conditions (e.g., insulin resistance) related to energy homeostasis have been increasingly discussed in various animal models and human cohorts. Remarkably, as the role of gut microbial metabolites as critical signaling molecules that function through the complementary host receptors has come to be appreciated, tremendous attention has been focused on the proposed diet-gut microbiota-host homeostasis axis, entailing extensive cross-disciplinary efforts in medical, pharmaceutical, and agricultural sciences. This review will discuss the recent advances in understanding the mechanisms whereby the gut microbiota modulates the effects of diet and shapes the host metabolism either towards or away from obesity and related metabolic conditions. In particular, the interactions of short chain fatty acids (SCFAs), a subset of key gut microbial metabolites, with their specific receptors will be reviewed in relation to host energy homeostatic regulation and evaluated for potential as novel therapeutic targets for diet-induced obesity.

[1]  Qiang Feng,et al.  A metagenome-wide association study of gut microbiota in type 2 diabetes , 2012, Nature.

[2]  P. Bork,et al.  Human gut microbes impact host serum metabolome and insulin sensitivity , 2016, Nature.

[3]  F. Bäckhed,et al.  Microbial modulation of insulin sensitivity. , 2014, Cell metabolism.

[4]  G. Tsujimoto,et al.  The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43 , 2013, Nature Communications.

[5]  Ajay S. Gulati,et al.  Akkermansia muciniphila mediates negative effects of IFNγ on glucose metabolism , 2016, Nature Communications.

[6]  S. Kahn,et al.  Mechanisms linking obesity to insulin resistance and type 2 diabetes , 2006, Nature.

[7]  Y. Sanz,et al.  Gut microbiota in obesity and metabolic disorders , 2010, Proceedings of the Nutrition Society.

[8]  Lee M. Kaplan,et al.  Conserved Shifts in the Gut Microbiota Due to Gastric Bypass Reduce Host Weight and Adiposity , 2013, Science Translational Medicine.

[9]  Masashi Yanagisawa,et al.  Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41 , 2008, Proceedings of the National Academy of Sciences.

[10]  A. Ichimura,et al.  Dietary Gut Microbial Metabolites, Short-chain Fatty Acids, and Host Metabolic Regulation , 2015, Nutrients.

[11]  J. Gordon,et al.  Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation , 2013, Proceedings of the National Academy of Sciences.

[12]  F. Bäckhed,et al.  Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits , 2014, Cell.

[13]  A. M. Habib,et al.  Short-Chain Fatty Acids Stimulate Glucagon-Like Peptide-1 Secretion via the G-Protein–Coupled Receptor FFAR2 , 2012, Diabetes.

[14]  Lucie Geurts,et al.  Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity , 2013, Proceedings of the National Academy of Sciences.

[15]  Jimmy D Bell,et al.  Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults , 2014, Gut.

[16]  B. Wicksteed,et al.  An Acetate-Specific GPCR, FFAR2, Regulates Insulin Secretion. , 2015, Molecular endocrinology.

[17]  N. Rubins,et al.  GPR41 modulates insulin secretion and gene expression in pancreatic β‐cells and modifies metabolic homeostasis in fed and fasting states , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  G. Tsujimoto,et al.  The SCFA Receptor GPR43 and Energy Metabolism , 2014, Front. Endocrinol..

[19]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[20]  P. Turnbaugh,et al.  Microbial ecology: Human gut microbes associated with obesity , 2006, Nature.

[21]  R. Gomis,et al.  Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice , 2015, Scientific Reports.

[22]  M. Cawthorne,et al.  Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acids , 2010, FEBS letters.

[23]  M. Blaser,et al.  Infant antibiotic exposures and early-life body mass , 2013, International Journal of Obesity.

[24]  Takafumi Hara,et al.  Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41) , 2011, Proceedings of the National Academy of Sciences.

[25]  S. Bloom,et al.  Peptides and their potential role in the treatment of diabetes and obesity. , 2011, The review of diabetic studies : RDS.

[26]  Stefan Offermanns,et al.  Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes , 2015, Nature Medicine.

[27]  W. D. de Vos,et al.  A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice , 2016, Nature Medicine.

[28]  Fredrik H. Karlsson,et al.  Gut metagenome in European women with normal, impaired and diabetic glucose control , 2013, Nature.

[29]  J. Gordon,et al.  Human nutrition, the gut microbiome and the immune system , 2011, Nature.

[30]  Ting Wang,et al.  The gut microbiota as an environmental factor that regulates fat storage. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[31]  G. Tsujimoto,et al.  Regulation of Energy Homeostasis by GPR41 , 2014, Front. Endocrinol..

[32]  F. Bäckhed,et al.  Effects of the gut microbiota on obesity and glucose homeostasis , 2011, Trends in Endocrinology & Metabolism.

[33]  Rik van der Kant,et al.  GPR43 Potentiates β-Cell Function in Obesity , 2015, Diabetes.

[34]  Demin Cai,et al.  Butyrate alleviates high fat diet-induced obesity through activation of adiponectin-mediated pathway and stimulation of mitochondrial function in the skeletal muscle of mice , 2016, Oncotarget.

[35]  J. Stockman,et al.  Metabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5 , 2012 .

[36]  H. Kiyono,et al.  Polyunsaturated fatty acid saturation by gut lactic acid bacteria affecting host lipid composition , 2013, Proceedings of the National Academy of Sciences.

[37]  M. Tomita,et al.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells , 2013, Nature.

[38]  F. Bäckhed,et al.  Dietary Fiber-Induced Improvement in Glucose Metabolism Is Associated with Increased Abundance of Prevotella. , 2015, Cell metabolism.

[39]  M. Blaser,et al.  Antibiotics in early life alter the murine colonic microbiome and adiposity , 2012, Nature.

[40]  Huidong Shi,et al.  Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. , 2014, Immunity.

[41]  E. Zoetendal,et al.  Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity. , 2014, Journal of hepatology.

[42]  R. Flavell,et al.  Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome , 2015, Nature Communications.

[43]  J. Auwerx,et al.  TGR5-mediated bile acid sensing controls glucose homeostasis. , 2009, Cell metabolism.

[44]  Takuya Suzuki,et al.  A Gut Microbial Metabolite of Linoleic Acid, 10-Hydroxy-cis-12-octadecenoic Acid, Ameliorates Intestinal Epithelial Barrier Impairment Partially via GPR40-MEK-ERK Pathway* , 2014, The Journal of Biological Chemistry.